Ilika plc Q&A with CFO Steve Boydell (LON:IKA)

Ilika plc

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss their final results, the importance of China, their ‘Goliath’ programme and more details on the placing and open offer.

 

Q1: You’ve released your results this morning and we can see that revenues have doubled, indicating the increasing commercial momentum. What measures are you taking to ensure this growth is sustained?

A1: We’ve deployed a team of four business development directors globally; in the US, China, Japan and here in Europe and close management of them is expected to sustain our growth this year and beyond.

 

Q2: I note that you’ve named three Stereax development programmes which look to be an exciting indicator or commercial traction; two are for industrial applications and one for medical. Does this split reflect the broader expressions in the interest Ilika has in technology?

A2: Industrial and medical are the two most important near-term sectors for us but more than half of the evaluations of our technology are actually with medical device companies.

 

Q3: One of your programmes is with Titan Wind in China, will this be an important jurisdiction, do you think?

A3: Very much so, yes. As I mentioned before, we have a business development director in China and one of our technical directors is just about to accompany him on a tour of potential partners there.

China have a large installed asset base that can benefit from industrial automation powered by our Stereax technology. There’s also significant interest in accessing our larger format battery technology to underpin China’s 5-year plan.

 

Q3: How do you intend to protect Ilika’s IP in China?

A3: That’s a good question. By careful screening of potential partners ensuring that they have a track record in international collaborations in which they respect patents.

 

Q4: You’ve just mentioned large format batteries, and I think they’re code named ‘Goliath’, has this become important part of your road map since January?

A4: Yes, we’ve had a lot of inbound interest and we’ve recently received significant offers of support from Innovate UK and are now putting together contracts in place with project partners.

 

Q5: You also announced today that you’ve completed a placing and initiated an open offer, what can you tell us about that?

A5: So, the placing is to ensure that Ilika have sufficient funds to invest in the capital equipment required for the ‘Goliath’ programme and to provide enough working capital for our other ongoing programmes. I would encourage retail investors to watch the video we’ve made in support of the open offer and I hope that they’ll choose to support the company through this exciting period of our development.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika takes solid-state battery message to major UK energy storage conference

Ilika will present its UK-developed quasi-solid-state cell technology at the Faraday Institution Conference 2026 in Nottingham, placing its Goliath programme within a major energy storage innovation forum.

Ilika Plc capital raise supports Stereax launch and Goliath progress, says Cavendish

Ilika’s latest Cavendish note highlights fresh funding to support Stereax commercialisation and Goliath development across medical, defence and e-bike markets.

Defence battery demand highlights a practical growth opportunity

Defence applications are increasing the need for safer, lighter and more reliable battery technology.

Ilika raises £4.56m in oversubscribed placing and subscription

Ilika has conditionally raised approximately £4.56 million through an oversubscribed placing and subscription, with proceeds to support the commercialisation of its Stereax and Goliath solid-state battery technologies.

Ilika launches Retail Offer to raise up to £0.5 Million

Ilika has opened a UK retail offer via BookBuild to raise up to £0.5 million, alongside a £4.56 million placing and directors’ subscription. Proceeds will support the commercial rollout of Stereax technology and further development of the Goliath battery programme.

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Search